 |
PDBsum entry 3bpm
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
3bpm
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Med Chem
52:852-857
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: implications for substrate specificity.
|
|
I.D.Kerr,
J.H.Lee,
K.C.Pandey,
A.Harrison,
M.Sajid,
P.J.Rosenthal,
L.S.Brinen.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Falcipain-2 and falcipain-3 are critical hemoglobinases of Plasmodium
falciparum, the most virulent human malaria parasite. We have determined the 2.9
A crystal structure of falcipain-2 in complex with the epoxysuccinate E64 and
the 2.5 A crystal structure of falcipain-3 in complex with the aldehyde
leupeptin. These complexes represent the first crystal structures of plasmodial
cysteine proteases with small molecule inhibitors and the first reported crystal
structure of falcipain-3. Our structural analyses indicate that the relative
shape and flexibility of the S2 pocket are affected by a number of discrete
amino acid substitutions. The cumulative effect of subtle differences, including
those at "gatekeeper" positions, may explain the observed kinetic differences
between these two closely related enzymes.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
R.Ettari,
M.Zappalà,
N.Micale,
G.Grazioso,
S.Giofrè,
T.Schirmeister,
and
S.Grasso
(2011).
Peptidomimetics containing a vinyl ketone warhead as falcipain-2 inhibitors.
|
| |
Eur J Med Chem,
46,
2058-2065.
|
 |
|
|
|
|
 |
V.Ehmke,
C.Heindl,
M.Rottmann,
C.Freymond,
W.B.Schweizer,
R.Brun,
A.Stich,
T.Schirmeister,
and
F.Diederich
(2011).
Potent and selective inhibition of cysteine proteases from Plasmodium falciparum and Trypanosoma brucei.
|
| |
ChemMedChem,
6,
273-278.
|
 |
|
|
|
|
 |
I.D.Kerr,
J.H.Lee,
C.J.Farady,
R.Marion,
M.Rickert,
M.Sajid,
K.C.Pandey,
C.R.Caffrey,
J.Legac,
E.Hansell,
J.H.McKerrow,
C.S.Craik,
P.J.Rosenthal,
and
L.S.Brinen
(2009).
Vinyl sulfones as antiparasitic agents and a structural basis for drug design.
|
| |
J Biol Chem,
284,
25697-25703.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.Xiao,
F.Jehle,
C.Peters,
T.Reinheckel,
R.H.Schirmer,
and
T.Dandekar
(2009).
CA/C1 peptidases of the malaria parasites Plasmodium falciparum and P. berghei and their mammalian hosts--a bioinformatical analysis.
|
| |
Biol Chem,
390,
1185-1197.
|
 |
|
|
|
|
 |
S.Subramanian,
M.Hardt,
Y.Choe,
R.K.Niles,
E.B.Johansen,
J.Legac,
J.Gut,
I.D.Kerr,
C.S.Craik,
and
P.J.Rosenthal
(2009).
Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3.
|
| |
PLoS ONE,
4,
e5156.
|
 |
|
|
|
|
 |
T.N.Wells,
P.L.Alonso,
and
W.E.Gutteridge
(2009).
New medicines to improve control and contribute to the eradication of malaria.
|
| |
Nat Rev Drug Discov,
8,
879-891.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |